Published ahead of print on September 29, 2005, doi:10.1165/rcmb.2005-0280OC
Am. J. Respir. Cell Mol. Biol., Volume 34, Number 2, February 2006, 174-181
A more recent version of this article appeared on February 1, 2006
Submitted on July 21, 2005
Revised on September 21, 2005
4-Hydroxynonenal Induces Rat Gamma-glutamyl Transpeptidase through MAPK Mediated EpRE/Nrf2 Signaling
Hongqiao Zhang1, Honglei Liu2, Karen E Iles3, Rui-Ming Liu4, Edward M Postlethwait4, Yannick Laperche5, and Henry Jay Forman2*
1 Department of Environmental Health Science, University of Alabama at Birmingham, Birmingham, AL, USA,
2 School of Natural Science, University of California at Merced, Merced, CA, USA,
3 Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA,
4 Department of Environmental Health Science, University of Alabama at Birmingham, Birmingham, AL, USA; Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, USA,
5 Institute of National de la Sante et la Researche Medicale, Hopital Henri Mondor, Creteil, France
* To whom correspondence should be addressed. E-mail: hforman{at}ucmerced.edu.
-Glutamyl transpeptidase (GGT) plays critical roles in glutathione homeostasis and metabolism. Rat GGT is a single copy gene from which seven types of GGT mRNA with a common protein encoding sequence, but different 5'-untranslated regions, may be transcribed. We previously showed that type V-2 was the predominant form of GGT mRNA in rat L2 epithelial cells and that it could be induced by 4-hydroxynonenal (HNE) through the electrophile response element located in GGT promoter 5 (GP5 EpRE). Here, we report transcription factors binding to GP5 EpRE and the involved signaling pathways. Immunodepletion gel shift assays demonstrated that GP5 EpRE bound JunB, c-Jun, FosB and Fra2 from unstimulated cells and that after exposure to HNE, EpRE binding complexes contained Nrf1, Nrf2, JunB, c-Jun, FosB, c-Fos, Fra1 and Fra2. HNE-induced binding of Nrf2 and c-Jun in GP5 EpRE was confirmed by chromatin immunoprecipitation assays. Using reporter assays and specific inhibitors, we found that HNE induction of rat GGT mRNA V-2 was dependent on activation of extracellular signal-regulated kinase (ERK) and p38MAPK, but not protein kinase C or phosphatidylinositol 3-kinase. Pretreatment with ERK and p38MAPK inhibitors also blocked HNE-increased EpRE binding. HNE-increased nuclear content of Nrf1, Nrf2 and c-Jun in L2 cells was partially blocked by inhibition of either ERK1/2 or p38MAPK and completely blocked by simultaneous inhibition of both MAPKs. In conclusion, HNE induces GGT mRNA V-2 through altered EpRE transcription factor binding mediated by both ERK and p38MAPK.
This article has been cited by other articles:

|
 |

|
 |
 
K. Ueda, T. Ueyama, K.-i. Yoshida, H. Kimura, T. Ito, Y. Shimizu, M. Oka, Y. Tsuruo, and M. Ichinose
Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions
Am J Physiol Gastrointest Liver Physiol,
September 1, 2008;
295(3):
G460 - G469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang and H. J. Forman
Acrolein Induces Heme Oxygenase-1 through PKC-{delta} and PI3K in Human Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
April 1, 2008;
38(4):
483 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Sibhatu, P. K. Smitherman, A. J. Townsend, and C. S. Morrow
Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane
Carcinogenesis,
April 1, 2008;
29(4):
807 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Purdom-Dickinson, E. V. Sheveleva, H. Sun, and Q. M. Chen
Translational Control of Nrf2 Protein in Activation of Antioxidant Response by Oxidants
Mol. Pharmacol.,
October 1, 2007;
72(4):
1074 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Blum, R. Elkon, S. Yaari, A. Zundelevich, J. Jacob-Hirsch, G. Rechavi, R. Shamir, and Y. Kloog
Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib (S-Farnesylthiosalicylic Acid)
Cancer Res.,
April 1, 2007;
67(7):
3320 - 3328.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|